Profile: Wockhardt Ltd (WCKH.BO)

WCKH.BO on Bombay Stock Exchange

1,562.75INR
31 Jul 2015
Change (% chg)

Rs75.20 (+5.06%)
Prev Close
Rs1,487.55
Open
Rs1,495.70
Day's High
Rs1,574.00
Day's Low
Rs1,493.20
Volume
197,044
Avg. Vol
277,814
52-wk High
Rs2,000.00
52-wk Low
Rs630.20

Search Stocks
Wockhardt Limited is an India-based pharmaceutical and biotechnology company. The Company also owns a chain of advanced super speciality hospitals. The Company offers treatment regimens for cardiology, neurosurgery, orthopaedics, critical care, oncology, nephrology and urology. The Company has filed ANDA applications for its products in the United States. The Company’s products include anti-infectives, cardiology, dermatology, diabetology, neurology, others, pain management and respiratory products. The Company’s product includes Ace Proxyvon, Aceroc, Alphadopa, Aziwok, B.G.Prot and Bio-Corneum. The Company’s subsidiaries include Wockhardt Biopharm Limited, Vinton Healthcare Limited, Wockhardt Infrastructure Development Limited, Wockhardt UK Holdings Limited, Wockhardt Bio AG and Wockhardt Europe Limited.

Company Address

Wockhardt Ltd

Wockhardt Towers
Bandra Kurla Complex, Bandra (Ea
Bandra (East)
MUMBAI     400051
P: +9122.26534444
F: +9122.26534242

Company Web Links

Search Stocks